$ONCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oncternal Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oncternal Therapeutics, Inc.. Get notifications about new insider transactions in Oncternal Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | ONCT | Oncternal Therapeu ... | Wills Robert James | Director | Option Exercise | A | 5.14 | 25,000 | 128,500 | 25,000 | |
May 27 2021 | ONCT | Oncternal Therapeu ... | MAZANET ROSEMARY | Director | Option Exercise | A | 5.14 | 25,000 | 128,500 | 25,000 | |
Mar 22 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 0.81 | 63,295 | 51,269 | 105,492 | |
Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 7.48 | 2,000 | 14,960 | 2,000 | |
Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.33 | 7,000 | 37,310 | 7,000 | |
Jan 28 2021 | ONCT | Oncternal Therapeu ... | MAZANET ROSEMARY | Director | Option Exercise | A | 5.33 | 30,000 | 159,900 | 30,000 | |
Sep 02 2020 | ONCT | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Buy | P | 2.10 | 71,429 | 150,001 | 71,947 | 518 to 71.9 K (+13,789.38 %) |
Sep 02 2020 | ONCT | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Buy | P | 2.10 | 71,429 | 150,001 | 71,947 | 518 to 71.9 K (+13,789.38 %) |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.32 | 5,000 | 11,600 | 5,000 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Buy | P | 2.38 | 10,000 | 23,825 | 10,000 | 0 to 10 K |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Option Exercise | A | 2.32 | 20,986 | 48,688 | 20,986 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Buy | P | 2.38 | 41,972 | 99,998 | 46,987 | 5 K to 47 K (+836.93 %) |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | Shanghai Pharmaceutical (USA) ... | 10% Owner | Option Exercise | P | 2.32 | 524,658 | 1,217,207 | 524,658 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | Shanghai Pharmaceutical (USA) ... | 10% Owner | Buy | P | 2.38 | 1,049,317 | 2,499,998 | 3,544,431 | 2.5 M to 3.5 M (+42.05 %) |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | Wills Robert James | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | THEUER CHARLES | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | Nakanishi Xin | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | LARUE WILLIAM R | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | HALE DAVID F | Director | Option Exercise | A | 2.94 | 22,500 | 66,150 | 22,500 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | Cho Man | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 3.33 | 66,890 | 222,744 | 66,890 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | VINCENT RICHARD G | Chief Financial Off ... | Option Exercise | A | 3.33 | 35,120 | 116,950 | 35,120 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | Kaufmann Gunnar F. | Chief Scientific Of ... | Option Exercise | A | 3.33 | 14,260 | 47,486 | 14,260 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | Hsu Frank J. | Chief Medical Offic ... | Option Exercise | A | 3.33 | 16,280 | 54,212 | 16,280 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | BILINSKY IGOR | Chief Business Offi ... | Option Exercise | A | 3.33 | 12,690 | 42,258 | 12,690 | |
Mar 18 2020 | ONCT | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Option Exercise | A | 3.33 | 11,080 | 36,896 | 11,080 | |
Jan 09 2020 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 4.13 | 22,000 | 90,860 | 22,000 | |
Dec 23 2019 | GTXI | Oncternal Therapeu ... | Cho Man | Director | Option Exercise | A | 4.11 | 30,000 | 123,300 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | Wills Robert James | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | THEUER CHARLES | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | Nakanishi Xin | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | Liu Yanjun | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | LARUE WILLIAM R | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | HALE DAVID F | Director | Option Exercise | A | 5.76 | 40,000 | 230,400 | 40,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | VINCENT RICHARD G | Chief Financial Off ... | Option Exercise | A | 5.76 | 75,000 | 432,000 | 75,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.76 | 100,000 | 576,000 | 100,000 | |
Sep 16 2019 | GTXI | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Option Exercise | A | 5.76 | 150,000 | 864,000 | 150,000 | |
Sep 09 2019 | GTXI | Oncternal Therapeu ... | Kaufmann Gunnar F. | Chief Scientific Of ... | Option Exercise | A | 5.19 | 150,000 | 778,500 | 150,000 | |
Sep 09 2019 | GTXI | Oncternal Therapeu ... | BILINSKY IGOR | Chief Business Offi ... | Option Exercise | A | 5.33 | 150,000 | 799,500 | 150,000 | |
Aug 28 2019 | GTXI | Oncternal Therapeu ... | Hsu Frank J. | Chief Medical Offic ... | Option Exercise | A | 5.64 | 150,000 | 846,000 | 150,000 | |
Jun 20 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.81 | 42,196 | 34,179 | 42,196 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | HALE DAVID F | Director | Option Exercise | A | 6.13 | 3,292 | 20,180 | 3,292 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | HALE DAVID F | Director | Grant | A | 0.00 | 18,346 | 0 | 18,346 | 0 to 18.3 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | HALE DAVID F | Director | Grant | A | 0.00 | 699,406 | 0 | 699,406 | 0 to 699.4 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | LARUE WILLIAM R | Director | Option Exercise | A | 6.13 | 281 | 1,723 | 281 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | LARUE WILLIAM R | Director | Grant | A | 0.00 | 10,030 | 0 | 10,030 | 0 to 10 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | LARUE WILLIAM R | Director | Grant | A | 0.00 | 16,144 | 0 | 16,144 | 0 to 16.1 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | VINCENT RICHARD G | Chief Financial Off ... | Option Exercise | A | 6.13 | 281 | 1,723 | 281 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | VINCENT RICHARD G | Chief Financial Off ... | Option Exercise | A | 0.81 | 73,385 | 59,442 | 73,385 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | VINCENT RICHARD G | Chief Financial Off ... | Grant | A | 0.00 | 1,834 | 0 | 1,834 | 0 to 1.8 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | VINCENT RICHARD G | Chief Financial Off ... | Grant | A | 0.00 | 4,526 | 0 | 4,526 | 0 to 4.5 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | VINCENT RICHARD G | Chief Financial Off ... | Grant | A | 0.00 | 42,628 | 0 | 40,794 | -1,834 to 40.8 K (-2,324.32 %) |
Jun 11 2019 | GTXI | GTX INC /DE/ | Shanghai Pharmaceutical (USA) ... | 10% Owner | Grant | A | 0.00 | 2,495,114 | 0 | 2,495,114 | 0 to 2.5 M |
Jun 11 2019 | GTXI | GTX INC /DE/ | THEUER CHARLES | Director | Grant | A | 0.00 | 14,677 | 0 | 14,677 | 0 to 14.7 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 6.13 | 733 | 4,493 | 733 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 1,467 | 998 | 1,467 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 117,417 | 79,844 | 117,417 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 21,544 | 0 | 21,544 | 0 to 21.5 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 733 | 0 | 733 | 0 to 733 |
Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 255,591 | 0 | 255,591 | 0 to 255.6 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | AKER HAZEL M | General Counsel | Option Exercise | A | 6.13 | 140 | 858 | 140 | |
Jun 11 2019 | GTXI | GTX INC /DE/ | AKER HAZEL M | General Counsel | Grant | A | 0.00 | 5,015 | 0 | 5,015 | 0 to 5 K |
Jun 11 2019 | GTXI | GTX INC /DE/ | AKER HAZEL M | General Counsel | Grant | A | 0.00 | 4,284 | 0 | 4,284 | 0 to 4.3 K |
Jan 03 2019 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.86 | 14,535 | 12,500 | 36,759 | 22.2 K to 36.8 K (+65.40 %) |
Oct 02 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 1.50 | 8,333 | 12,500 | 22,224 | 13.9 K to 22.2 K (+59.99 %) |
Oct 02 2018 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 1.50 | 8,917 | 13,376 | 44,105 | 35.2 K to 44.1 K (+25.34 %) |
Oct 02 2018 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 1.50 | 10,417 | 15,626 | 1,939,199 | 1.9 M to 1.9 M (+0.54 %) |
Jul 17 2018 | GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical O ... | Buy | S | 14.70 | 2,049 | 30,120 | 45,936 | 43.9 K to 45.9 K (+4.67 %) |
Jul 17 2018 | GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical O ... | Payment of Exercise | F | 14.92 | 2,014 | 30,049 | 47,985 | 50 K to 48 K (-4.03 %) |
Jul 03 2018 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 15.47 | 865 | 13,382 | 35,189 | 34.3 K to 35.2 K (+2.52 %) |
Jul 03 2018 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 15.47 | 1,010 | 15,625 | 1,928,783 | 1.9 M to 1.9 M (+0.05 %) |
Jul 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 15.47 | 808 | 12,500 | 13,891 | 13.1 K to 13.9 K (+6.18 %) |
Jun 26 2018 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Buy | P | 16.75 | 5,000 | 83,750 | 137,344 | 132.3 K to 137.3 K (+3.78 %) |
Jun 22 2018 | GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Off ... | Sell | S | 19.01 | 7,351 | 139,708 | 43,630 | 51 K to 43.6 K (-14.42 %) |
Jun 22 2018 | GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. O ... | Sell | S | 19.01 | 9,279 | 176,350 | 19,453 | 28.7 K to 19.5 K (-32.30 %) |
May 11 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Option Exercise | A | 17.20 | 7,500 | 129,000 | 7,500 | |
Apr 03 2018 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 17.47 | 766 | 13,382 | 34,324 | 33.6 K to 34.3 K (+2.28 %) |
Apr 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 17.47 | 716 | 12,509 | 13,083 | 12.4 K to 13.1 K (+5.79 %) |
Apr 03 2018 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 17.47 | 766 | 13,382 | 34,324 | 33.6 K to 34.3 K (+2.28 %) |
Apr 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 17.47 | 716 | 12,509 | 13,083 | 12.4 K to 13.1 K (+5.79 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Sell | S | 11.13 | 5,628 | 62,640 | 124,362 | 130 K to 124.4 K (-4.33 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Sell | S | 12.02 | 1,681 | 20,206 | 129,990 | 131.7 K to 130 K (-1.28 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. O ... | Sell | S | 11.13 | 2,379 | 26,478 | 28,732 | 31.1 K to 28.7 K (-7.65 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. O ... | Sell | S | 12.02 | 711 | 8,546 | 31,111 | 31.8 K to 31.1 K (-2.23 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Off ... | Sell | S | 11.13 | 3,823 | 42,550 | 50,981 | 54.8 K to 51 K (-6.98 %) |
Jan 09 2018 | GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Off ... | Sell | S | 12.02 | 1,142 | 13,727 | 54,804 | 55.9 K to 54.8 K (-2.04 %) |
Jan 04 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 11.46 | 1,091 | 12,503 | 12,367 | 11.3 K to 12.4 K (+9.68 %) |
Jan 04 2018 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 11.46 | 1,363 | 15,620 | 1,734,893 | 1.7 M to 1.7 M (+0.08 %) |
Jan 04 2018 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 11.46 | 1,167 | 13,374 | 33,558 | 32.4 K to 33.6 K (+3.60 %) |
Oct 04 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 7.94 | 1,574 | 12,498 | 11,277 | 9.7 K to 11.3 K (+16.22 %) |
Oct 04 2017 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 7.94 | 1,685 | 13,379 | 32,391 | 30.7 K to 32.4 K (+5.49 %) |
Oct 04 2017 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 7.94 | 1,968 | 15,626 | 3,983,530 | 4 M to 4 M (+0.05 %) |
Oct 02 2017 | GTXI | GTX INC /DE/ | Pyramid Peak Foundation | 10% Owner | Option Exercise | P | 9.02 | 339,174 | 3,059,349 | 339,174 | |
Oct 02 2017 | GTXI | GTX INC /DE/ | Pyramid Peak Foundation | 10% Owner | Buy | P | 0.00 | 565,291 | 0 | 4,390,243 | 3.8 M to 4.4 M (+14.78 %) |
Oct 02 2017 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Option Exercise | A | 9.02 | 678,349 | 6,118,708 | 678,349 | |
Oct 02 2017 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 1,130,582 | 0 | 3,981,562 | 2.9 M to 4 M (+39.66 %) |
Apr 05 2017 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 4.90 | 3,189 | 15,626 | 2,075,287 | 2.1 M to 2.1 M (+0.15 %) |
Apr 05 2017 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 4.90 | 2,730 | 13,377 | 28,164 | 25.4 K to 28.2 K (+10.73 %) |
Apr 05 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 4.90 | 2,551 | 12,500 | 7,326 | 4.8 K to 7.3 K (+53.42 %) |
Mar 02 2017 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Option Exercise | A | 4.71 | 95,000 | 447,450 | 95,000 | |
Mar 02 2017 | GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Off ... | Option Exercise | A | 4.71 | 80,000 | 376,800 | 80,000 | |
Jan 04 2017 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 5.21 | 2,999 | 15,625 | 4,322,099 | 4.3 M to 4.3 M (+0.07 %) |
Jan 04 2017 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 5.21 | 2,567 | 13,374 | 25,434 | 22.9 K to 25.4 K (+11.23 %) |
Jan 04 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 5.21 | 2,399 | 12,499 | 4,775 | 2.4 K to 4.8 K (+100.97 %) |
Oct 17 2016 | GTXI | GTX INC /DE/ | Pyramid Peak Foundation | 10% Owner | Buy | P | 0.81 | 7,716,049 | 6,250,000 | 38,249,528 | 30.5 M to 38.2 M (+25.27 %) |
Oct 17 2016 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.81 | 7,716,049 | 6,250,000 | 43,191,009 | 35.5 M to 43.2 M (+21.75 %) |
Oct 17 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Grant | A | 0.81 | 123,456 | 99,999 | 1,380,680 | 1.3 M to 1.4 M (+9.82 %) |
Oct 17 2016 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Grant | A | 0.81 | 123,456 | 99,999 | 1,323,456 | 1.2 M to 1.3 M (+10.29 %) |
Oct 04 2016 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 20,559 | 0 | 35,474,960 | 35.5 M to 35.5 M (+0.06 %) |
Oct 04 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 16,447 | 0 | 23,757 | 7.3 K to 23.8 K (+224.99 %) |
Oct 04 2016 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 17,599 | 0 | 228,672 | 211.1 K to 228.7 K (+8.34 %) |
Sep 06 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 7,310 | 0 | 7,310 | 0 to 7.3 K |
Sep 01 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Option Exercise | A | 0.58 | 100,000 | 58,000 | 100,000 | |
Jul 05 2016 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 24,318 | 0 | 211,074 | 186.8 K to 211.1 K (+13.02 %) |
Jul 05 2016 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 28,409 | 0 | 33,354,225 | 33.3 M to 33.4 M (+0.09 %) |
May 06 2016 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Option Exercise | A | 0.71 | 50,000 | 35,500 | 50,000 | |
May 06 2016 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Option Exercise | A | 0.71 | 50,000 | 35,500 | 50,000 | |
May 06 2016 | GTXI | GTX INC /DE/ | CARTER MICHAEL G | Director | Option Exercise | A | 0.71 | 50,000 | 35,500 | 50,000 | |
Apr 04 2016 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 27,902 | 0 | 29,325,856 | 29.3 M to 29.3 M (+0.10 %) |
Apr 04 2016 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 23,884 | 0 | 186,755 | 162.9 K to 186.8 K (+14.66 %) |
Mar 02 2016 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 0.60 | 44,000 | 26,400 | 183,768 | 139.8 K to 183.8 K (+31.48 %) |
Jan 26 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Buy | P | 0.65 | 4,000 | 2,600 | 1,257,224 | 1.3 M to 1.3 M (+0.32 %) |
Jan 25 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Buy | P | 0.63 | 12,813 | 8,067 | 1,253,224 | 1.2 M to 1.3 M (+1.03 %) |
Jan 19 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Buy | P | 0.50 | 25,000 | 12,428 | 1,240,411 | 1.2 M to 1.2 M (+2.06 %) |
Jan 15 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Buy | P | 0.47 | 2,900 | 1,377 | 1,193,311 | 1.2 M to 1.2 M (+0.24 %) |
Jan 15 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Buy | P | 0.49 | 22,100 | 10,889 | 1,215,411 | 1.2 M to 1.2 M (+1.85 %) |
Jan 05 2016 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 18,838 | 0 | 162,872 | 144 K to 162.9 K (+13.08 %) |
Jan 05 2016 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 22,007 | 0 | 29,297,984 | 29.3 M to 29.3 M (+0.08 %) |
Jan 04 2016 | GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. O ... | Option Exercise | A | 0.70 | 175,000 | 122,500 | 175,000 | |
Jan 04 2016 | GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Off ... | Option Exercise | A | 0.70 | 400,000 | 280,000 | 400,000 | |
Jan 04 2016 | GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Off ... | Option Exercise | A | 0.70 | 250,000 | 175,000 | 250,000 | |
Jan 04 2016 | GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical O ... | Option Exercise | A | 0.70 | 150,000 | 105,000 | 150,000 | |
Jan 04 2016 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Option Exercise | A | 0.70 | 400,000 | 280,000 | 400,000 | |
Dec 28 2015 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 0.79 | 100 | 79 | 139,768 | 139.7 K to 139.8 K (+0.07 %) |
Dec 23 2015 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 0.78 | 1,307 | 1,019 | 139,068 | 137.8 K to 139.1 K (+0.95 %) |
Dec 23 2015 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 0.79 | 600 | 474 | 139,668 | 139.1 K to 139.7 K (+0.43 %) |
Dec 21 2015 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 0.78 | 39,900 | 31,122 | 137,761 | 97.9 K to 137.8 K (+40.77 %) |
Oct 02 2015 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 19,500 | 0 | 29,275,977 | 29.3 M to 29.3 M (+0.07 %) |
Oct 02 2015 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 16,500 | 0 | 144,034 | 127.5 K to 144 K (+12.94 %) |
Jul 15 2015 | GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical O ... | Grant | A | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Jul 02 2015 | GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Grant | A | 0.00 | 9,685 | 0 | 28,183,805 | 28.2 M to 28.2 M (+0.03 %) |
Jul 02 2015 | GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Grant | A | 0.00 | 8,195 | 0 | 127,534 | 119.3 K to 127.5 K (+6.87 %) |
May 20 2015 | GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Buy | P | 1.25 | 24,500 | 30,625 | 24,500 | 0 to 24.5 K |
May 14 2015 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Buy | P | 0.98 | 36,440 | 35,711 | 100,000 | 63.6 K to 100 K (+57.33 %) |
May 14 2015 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Buy | P | 0.88 | 9,700 | 8,536 | 63,560 | 53.9 K to 63.6 K (+18.01 %) |
May 13 2015 | GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Buy | P | 0.80 | 3,860 | 3,088 | 53,860 | 50 K to 53.9 K (+7.72 %) |